| Ident. | Authors (with country if any) | Title |
|---|
| 001315 |
Miguel Martin [Espagne] ; Richard Bell [Australie] ; Hugues Bourgeois [France] ; Adam Brufsky [États-Unis] ; Ingo Diel [Allemagne] ; Alexandru Eniu [Roumanie] ; Lesley Fallowfield [Royaume-Uni] ; Yasuhiro Fujiwara [Japon] ; Jacek Jassem [Pologne] ; Alexander H. G. Paterson [Canada] ; Diana Ritchie [Royaume-Uni] ; Gunther G. Steger [Autriche] ; Alison Stopeck [États-Unis] ; Charles Vogel [États-Unis] ; Michelle Fan [États-Unis] ; QI JIANG [Allemagne] ; Karen Chung [États-Unis] ; Roger Dansey [États-Unis] ; Ada Braun [États-Unis] | Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid |
| 001317 |
Philip N. Sambrook [Australie] ; Christian Roux [France] ; Jean-Pierre Devogelaer [Belgique] ; Kenneth Saag [États-Unis] ; Chak-Sing Lau [Royaume-Uni] ; Jean-Yves Reginster [Belgique] ; Christina Bucci-Rechtweg [États-Unis] ; GUOQIN SU [États-Unis] ; David M. Reid [Royaume-Uni] | Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate |
| 002623 |
B. Le Goff [France, Australie] ; J.-M. Berthelot [France] ; Y. Maugars [France] ; E. Romas [Australie] | Alternative Use of Bisphosphonate Therapy for Rheumatic Disease |
| 002701 |
David M. Reid [Royaume-Uni] ; Jean-Pierre Devogelaer [Belgique] ; Kenneth Saag [États-Unis] ; Christian Roux [France] ; Chak-Sing Lau [Royaume-Uni] ; Jean-Yves Reginster [Belgique] ; Philemon Papanastasiou [Suisse] ; Alberto Ferreira [Suisse] ; Florian Hartl [Suisse] ; Taiwo Fashola [Suisse] ; Peter Mesenbrink [États-Unis] ; Philip N. Sambrook [Australie] | Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON) : a multicentre, double-blind, double-dummy, randomised controlled trial |
| 003276 |
Nigel J. Bundred [Royaume-Uni] ; Ian D. Campbell [Nouvelle-Zélande] ; Neville Davidson [Royaume-Uni] ; Richard H. Deboer [Australie] ; Holger Eidtmann [Allemagne] ; Alain Monnier [France] ; Patrick Neven [Belgique] ; Gunter Von Minckwitz [Allemagne] ; Joel C. Miller [États-Unis] ; Nora L. Schenk [États-Unis] ; Robert E. Coleman [Royaume-Uni] | Effective Inhibition of Aromatase Inhibitor-associated Bone Loss by Zoledronic Acid in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole : ZO-FAST Study Results |
| 005599 |
P. Major [Canada, France, États-Unis, Australie, Allemagne, Belgique, Suisse] ; A. Lortholary ; J. Hon ; E. Abdi ; G. Mills ; H. D. Menssen ; F. Yunus ; R. Bell ; J. Body ; E. Quebe-Fehling ; J. Seaman | Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy : A pooled analysis of two randomized, controlled clinical trials |
